Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 87 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Antifungal Agents [Clear All Filters]
Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries..
BMC Infect Dis. 16(1), 667.
(2016). Isavuconazole: an azole active against mucormycosis..
Lancet Infect Dis. 16(7), 761-762.
(2016). In vitro and in vivo study on the effect of antifungal agents on hematopoietic cells in mice..
Exp Biol Med (Maywood). 240(12), 1728-34.
(2015). In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms..
J Antimicrob Chemother. 70(2), 470-8.
(2015). Invasive candidiasis and candidaemia in neonates and children: update on current guidelines..
Mycoses. 58(1), 10-21.
(2015). Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study..
Antimicrob Agents Chemother. 59(2), 782-9.
(2015). Therapeutic strategies for invasive fungal infections in neonatal and pediatric patients: an update..
Expert Opin Pharmacother. 16(5), 693-710.
(2015). Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome..
J Infect. 68(5), 478-93.
(2014). Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii..
Antimicrob Agents Chemother. 58(8), 4953-6.
(2014). ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013..
Clin Microbiol Infect. 20 Suppl 3, 5-26.
(2014). ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi..
Clin Microbiol Infect. 20 Suppl 3, 47-75.
(2014). ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others..
Clin Microbiol Infect. 20 Suppl 3, 27-46.
(2014). Exserohilum infections: review of 48 cases before the 2012 United States outbreak..
Med Mycol. 52(4), 376-86.
(2014). Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation..
Lancet Oncol. 15(8), e327-40.
(2014). In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds..
Antimicrob Agents Chemother. 58(11), 6934-7.
(2014). Micafungin in premature and non-premature infants: a systematic review of 9 clinical trials..
Pediatr Infect Dis J. 33(11), e291-8.
(2014). Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs..
Mycoses. 57 Suppl 3, 40-7.
(2014). Why is mucormycosis more difficult to cure than more common mycoses?.
Clin Microbiol Infect. 20 Suppl 6, 74-81.
(2014). Invasive candidiasis in pediatric intensive care in Greece: a nationwide study..
Intensive Care Med. 39(12), 2188-95.
(2013). Invasive candidiasis: update on current pharmacotherapy options and future perspectives..
Expert Opin Pharmacother. 14(11), 1515-28.
(2013). Non-Aspergillus fungal infections in chronic granulomatous disease..
Mycoses. 56(4), 449-62.
(2013). A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts..
Intensive Care Med. 39(12), 2092-106.
(2013). What can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis?.
Clin Infect Dis. 57(6), 853-9.
(2013). Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011)..
Clin Infect Dis. 55(10), 1338-51.
(2012). Combination therapy for mucormycosis: why, what, and how?.
Clin Infect Dis. 54 Suppl 1, S73-8.
(2012).